Photochemical internalisation in drug and gene delivery.
暂无分享,去创建一个
Kristian Berg | K. Berg | A. Høgset | P. Selbo | L. Prasmickaite | M. Hellum | B. Engesaeter | A. Bonsted | Lina Prasmickaite | Anders Høgset | Pål K Selbo | Marit Hellum | Birgit Ø Engesaeter | Anette Bonsted
[1] J P Cooke,et al. Photoangioplasty for Human Peripheral Atherosclerosis: Results of a Phase I Trial of Photodynamic Therapy With Motexafin Lutetium (Antrin) , 2000, Circulation.
[2] I Rosenthal,et al. PHTHALOCYANINES AS PHOTODYNAMIC SENSITIZERS * , 1991, Photochemistry and photobiology.
[3] E. Keystone,et al. Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. , 1998, Arthritis and rheumatism.
[4] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Berg,et al. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31‐gelonin , 2000, International journal of cancer.
[6] G. Kroemer,et al. Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. , 2001, Cancer research.
[7] L. Barbieri,et al. Ribosome-inactivating proteins from plants. , 1993, Biochimica et Biophysica Acta.
[8] A. Moor,et al. The photodecontamination of cellular blood components: mechanisms and use of photosensitization in transfusion medicine. , 1996, Transfusion medicine reviews.
[9] K. Berg,et al. Evaluation of Different Photosensitizers for Use in Photochemical Gene Transfection¶ , 2001, Photochemistry and photobiology.
[10] F. Stirpe,et al. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. , 1980, The Journal of biological chemistry.
[11] K. König,et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.
[12] C. Regillo. Update on photodynamic therapy. , 2000, Current opinion in ophthalmology.
[13] J Moan,et al. PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH , 1992, Photochemistry and photobiology.
[14] P. Ghosh,et al. Interaction of gelonin with macrophages: effect of lysosomotropic amines. , 1992, Experimental cell research.
[15] C. Plank,et al. Application of membrane-active peptides for drug and gene delivery across cellular membranes. , 1998, Advanced drug delivery reviews.
[16] K. Berg,et al. THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.
[17] H. Pass,et al. Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.
[18] Kristian Berg,et al. In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy , 2001, International journal of cancer.
[19] K. Berg,et al. Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses , 2004, Gene Therapy.
[20] K. Berg,et al. Photochemical transfection: a new technology for light-induced, site-directed gene delivery. , 2000, Human gene therapy.
[21] J Moan,et al. INTRACELLULAR LOCALIZATION OF SULFONATED meso‐TETRAPHENYLPORPHINES IN A HUMAN CARCINOMA CELL LINE * , 1990, Photochemistry and photobiology.
[22] Kristian Berg,et al. Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy , 2002, Cancer Gene Therapy.
[23] K Mechtler,et al. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.
[24] J Moan,et al. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.
[25] D. Lane,et al. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. , 2001, Bioconjugate chemistry.
[26] A. Moor,et al. Photodynamic sterilization of red cells and its effect on contaminating white cells: viability and mechanism of cell death , 1999, Transfusion.
[27] N. Oleinick,et al. Mutagenicity of Photodynamic Therapy as Compared to UVC and Ionizing Radiation in Human and Murine Lymphoblast Cell Lines , 1997, Photochemistry and photobiology.
[28] J. Newman,et al. Photodynamic therapy of viral contaminants with potential for blood banking applications , 1988, Transfusion.
[29] B. Davidson,et al. Complexes of Adenovirus with Polycationic Polymers and Cationic Lipids Increase the Efficiency of Gene Transfer in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.
[30] S. Agrawal,et al. Antisense and/or immunostimulatory oligonucleotide therapeutics. , 2001, Current cancer drug targets.
[31] A. Nixon. Phage display as a tool for protease ligand discovery. , 2002, Current pharmaceutical biotechnology.
[32] J Moan,et al. Intracellular localization of photosensitizers. , 1989, Ciba Foundation symposium.
[33] K. Berg,et al. Sulfonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells , 1994, International journal of cancer.
[34] K. Berg,et al. Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization. , 2000, Biochimica et biophysica acta.
[35] G. Stables,et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.
[36] K. Berg,et al. Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy , 2002, British Journal of Cancer.
[37] J D Waterfield,et al. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant‐enhanced arthritis in MRL‐lpr mice , 1994, Clinical and experimental immunology.
[38] M. Jung,et al. Inhibitors of histone deacetylase as new anticancer agents. , 2001, Current medicinal chemistry.
[39] Ari Helenius,et al. Stepwise dismantling of adenovirus 2 during entry into cells , 1993, Cell.
[40] Allen Cm,et al. Role of activated oxygen species in photodynamic therapy. , 2000 .
[41] D. Phillips,et al. Kinetic and equilibrium studies of incorporation of di-sulfonated aluminum phthalocyanine into unilamellar vesicles. , 1999, Biochimica et biophysica acta.
[42] Tayyaba Hasan,et al. Photodynamic Treatment of Rheumatoid and Inflammatory Arthritis , 1996, Photochemistry and photobiology.
[43] Q. Peng,et al. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. , 1995, British Journal of Cancer.
[44] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[45] Inder M. Verma,et al. Gene therapy: trials and tribulations , 2000, Nature Reviews Genetics.
[46] I. Kirby,et al. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by αvβ1 integrin and can be modulated by changes in β1 integrin function , 2001, The journal of gene medicine.
[47] K. Tsurugi,et al. The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins. , 1988, Biochemical and biophysical research communications.
[48] G. LaMuraglia,et al. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. , 2000, The American journal of pathology.
[49] I. Tannock,et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer , 2000, Nature Medicine.
[50] M. Wu. Enhancement of immunotoxin activity using chemical and biological reagents. , 1997, British Journal of Cancer.
[51] P. Robbins. Gene therapy protocols , 1996 .
[52] A. Urtti,et al. Cell membranes as barriers for the use of antisense therapeutic agents. , 2002, Mini reviews in medicinal chemistry.
[53] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[54] Kendric C. Smith,et al. Topics In Photomedicine , 1984 .
[55] K. Berg,et al. Photochemical Transfection: A Technology for Efficient Light-Directed Gene Delivery , 2002, Somatic cell and molecular genetics.
[56] G. Mælandsmo,et al. Light directed gene transfer by photochemical internalisation. , 2003, Current gene therapy.
[57] Kristian Berg,et al. Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. , 2003, Cancer research.
[58] J. Schneider,et al. Hematoporphyrin uptake in atherosclerotic plaques: therapeutic potentials. , 1988, Neurosurgery.
[59] A. S. Sobolev,et al. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency , 2000, Immunology and cell biology.
[60] H Anholt,et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.
[61] B. Epe,et al. Oxidative DNA base damage induced by singlet oxygen and photosensitization: recognition by repair endonucleases and mutagenicity. , 2000, Mutation research.
[62] J Moan,et al. Lysosomes as photochemical targets , 1994, International journal of cancer.
[63] W. Cheong,et al. Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. , 2000, Circulation.
[64] C. Pournaras,et al. Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration. , 1999, Seminars in ophthalmology.
[65] R. Ward,et al. Application of phage display technology to cancer research. , 2002, Current pharmaceutical biotechnology.
[66] R. Crystal,et al. Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors , 1999, Journal of Virology.
[67] I. Kochevar,et al. [2] Photosensitized production of singlet oxygen , 2000 .
[68] D. McDonald,et al. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells , 1999, Gene Therapy.
[69] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[70] G. Powis,et al. A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity. , 1994, Anti-cancer drug design.
[71] T J Dougherty,et al. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.
[72] L. Mir,et al. Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. , 1999, Biochemical pharmacology.
[73] A. Fischer,et al. Gene therapy of severe combined immunodeficiencies , 2002, Nature Reviews Immunology.
[74] K. Berg,et al. CELLULAR UPTAKE AND RELATIVE EFFICIENCY IN CELL INACTIVATION BY PHOTO ACTIVATED SULFONATED meso‐TETRAPHENYLPORPHINES , 1990, Photochemistry and photobiology.
[75] T J Flotte,et al. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. , 1992, Circulation.
[76] A. Mountain,et al. Gene therapy: the first decade. , 2000, Trends in biotechnology.
[77] D. Scheinberg,et al. Immunotoxin resistance in multidrug resistant cells. , 2003, Cancer research.
[78] A. Yamaguchi,et al. Reduction of Vein Graft Disease Using Photodynamic Therapy with Motexafin Lutetium in a Rodent Isograft Model , 2000, Circulation.
[79] N. Hackett,et al. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. , 1998, Human gene therapy.
[80] Bertrand Tavitian,et al. Nucleic acid aptamers in cancer medicine , 2002, FEBS letters.
[81] L. Mir,et al. Bleomycin: revival of an old drug. , 1996, General pharmacology.